Clinical Trial Update: A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010 [Phase 1]

View source ↗

Summary

Phase 1 randomized crossover study in healthy subjects to assess relative bioavailability of PT010; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• PT010

Snippet

Sponsor: Pearl Therapeutics, Inc. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED | Results posted: 2020-06-11